BD to Acquire HandyLab
Becton, Dickinson and Co. (Franklin Lakes, NJ) is acquiring HandyLab Inc. (Ann Arbor, MI) to further expand into "other molecular opportunities," according to BD President Vincent Forlenza. The acquisition is part of a strategy that builds on a development and distribution agreement between the two companies earlier this year. BD plans to integrate its GeneOhm molecular assay for MRSA and VRE (Vancomycin-resistant Enterococcus) with HandyLab's platform technology.
October 26, 2009
1 Min Read
The combined technology will be marketed as the BD Max system. More details about the acquisition will be made during BD's fourth quarter earnings call next week.
Sign up for the QMED & MD+DI Daily newsletter.
You May Also Like